Invasc Therapeutics -Developing first-in-class drugs for the cardiometabolic market
Invasc Therapeutics -Developing first-in-class drugs for the cardiometabolic market

Products

InVasc’s core strengths include an in-depth understanding of common metabolic pathways and treatment options for CKD, cardiovascular disease, cardiovascular imaging and drug development. These strengths have led to the identification of four target areas with multiple drug candidates associated with each. We current have one active IND and anticipate having multiple drugs in clinical development within the next two years.